PAMELA RIVERA: Open Payments
NPI 1558442061 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 8 payments from 5 companies in 2025. Trend: 2023 $260 · 2024 $233 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: REXULTI, CAPLYTA, Auvelity, ARISTADA, INGREZZA.
Industry payments across OR — which companies pay providers there.
